| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f85b929be91a05f4459f6bdaadeec2f5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23J1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 |
| filingDate |
2014-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2fbcaca1aeeb259470e69c0fcfd2a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2d8943182848f2e4cd36862c1db464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d748d584564a95d33a26789872a25500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e89a25cab1ec43403c00b838766b8e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e35fa5729aac974d67f5c4fc1c58121a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287a0fb80925d9ad055770c817fdb8c0 |
| publicationDate |
2020-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I686204-B |
| titleOfInvention |
Use of milk-derived basic protein fraction and/or a degradation product of a milk-derived basic protein fraction, and a whey protein hydrosylate |
| abstract |
The invention provides a muscle atrophy prevention and/or muscle synthesis promotion agent containing, as active ingredients, a milk-derived basic protein fraction and/or a degradation product of a milk-derived basic protein fraction, and a whey protein hydrosylate. This muscle atrophy prevention and/or muscle synthesis promotion agent exhibits remarkable effects in terms of preventing a reduction in nmuscle mass and increasing muscle mass, and is therefore effective in the prevention and treatment of various muscular diseases including sarcopenia and disuse muscle atrophy. |
| priorityDate |
2013-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |